PHI with Intermediate coronary syndrome (Graybiel)
How does this condition affect your private health insurance?
Intermediäres Koronarsyndrom, also known as Graybiel's syndrome, describes unstable angina, a critical manifestation of coronary artery disease. It represents a state of myocardial ischemia (lack of blood flow to the heart muscle) that is more severe, prolonged, or occurs with less exertion than stable angina. Unlike a full myocardial infarction, there is no irreversible heart muscle damage initially, but it carries a high risk of progressing to one. Symptoms include chest pain or discomfort, often radiating to the arm, neck, or jaw, which may occur at rest or awaken the patient from sleep. Prompt medical evaluation and intervention are crucial to prevent further cardiac events and preserve heart function. It signifies an acute, worsening condition of coronary atherosclerosis requiring immediate attention.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute episodes typically last minutes to hours; hospitalization and initial stabilization may span several days.
Duration of Illness (Lifetime)
Chronic disease requiring lifelong management due to underlying coronary artery disease.
Cost of Treatment (Initial)
High (e.g., $5,000 - $30,000) for emergency care, diagnostics, hospitalization, and initial medication/intervention.
Cost of Treatment (Lifetime)
Very High (e.g., $50,000 - $500,000+) including lifelong medication, follow-ups, and potential repeat interventions.
Mortality Rate
Moderate (e.g., 2-5% with prompt treatment, higher without) at the time of acute event or shortly thereafter.
Risk of Secondary Damages
High (e.g., 20-40% risk of progression to myocardial infarction, heart failure, or severe arrhythmias within weeks if not effectively managed).
Probability of Full Recovery
Low for complete recovery without any underlying consequences or need for ongoing management; high for acute stabilization and symptom control with appropriate treatment.
Underlying Disease Risk
Extremely high for Coronary Artery Disease (atherosclerosis); high for hypertension, diabetes, dyslipidemia, and metabolic syndrome as predisposing factors.